The health care industry is still parsing the effects of the Supreme Court’s recent decisions in Loper Bright Enterprises v. Raimondo, which ends Chevron deference, and SEC v. Jarkesy, which entitles defendants to a jury trial when the government seeks civil penalties.
Our Jonathan Porter, along with Greg Demske at Goodwin Procter LLP, joins host Chip Hutzler on AHLA's Speaking of Health Law to discuss how these decisions will impact the health care industry. They cover which health care regulations may come under closer scrutiny after Loper Bright and the kinds of health care civil penalties that may be affected under Jarkesy. Jonathan recently co-authored an article for Health Law Weekly on this topic.
From AHLA’s Fraud and Abuse Practice Group. Sponsored by HMS Valuation Partners.